Annual Accounts Payable
$520.00 M
+$33.00 M+6.78%
31 December 2023
Summary:
Moderna annual accounts payable is currently $520.00 million, with the most recent change of +$33.00 million (+6.78%) on 31 December 2023. During the last 3 years, it has risen by +$218.00 million (+72.19%). MRNA annual accounts payable is now at all-time high.MRNA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$373.00 M
+$94.00 M+33.69%
30 September 2024
Summary:
Moderna quarterly accounts payable is currently $373.00 million, with the most recent change of +$94.00 million (+33.69%) on 30 September 2024. Over the past year, it has dropped by -$147.00 million (-28.27%). MRNA quarterly accounts payable is now -28.27% below its all-time high of $520.00 million, reached on 31 December 2023.MRNA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -28.3% |
| 3 y3 years | +72.2% | +23.5% |
| 5 y5 years | +7234.3% | +5160.9% |
MRNA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +72.2% | -28.3% | +106.1% |
| 5 y | 5 years | at high | +7234.3% | -28.3% | +5160.9% |
| alltime | all time | at high | >+9999.0% | -28.3% | >+9999.0% |
Moderna Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $373.00 M(+33.7%) |
| June 2024 | - | $279.00 M(+52.5%) |
| Mar 2024 | - | $183.00 M(-64.8%) |
| Dec 2023 | $520.00 M(+6.8%) | $520.00 M(+5.3%) |
| Sept 2023 | - | $494.00 M(+59.4%) |
| June 2023 | - | $310.00 M(-20.3%) |
| Mar 2023 | - | $389.00 M(-20.1%) |
| Dec 2022 | $487.00 M(+61.3%) | $487.00 M(+47.6%) |
| Sept 2022 | - | $330.00 M(+82.3%) |
| June 2022 | - | $181.00 M(-9.0%) |
| Mar 2022 | - | $199.00 M(-34.1%) |
| Dec 2021 | $302.00 M(+1577.8%) | $302.00 M(+247.1%) |
| Sept 2021 | - | $87.00 M(+13.0%) |
| June 2021 | - | $77.00 M(+862.5%) |
| Mar 2021 | - | $8.00 M(-55.6%) |
| Dec 2020 | $18.00 M(+153.9%) | $18.00 M(-12.3%) |
| Sept 2020 | - | $20.52 M(+9.1%) |
| June 2020 | - | $18.82 M(+70.5%) |
| Mar 2020 | - | $11.03 M(+55.6%) |
| Dec 2019 | $7.09 M(-77.3%) | $7.09 M(-39.6%) |
| Sept 2019 | - | $11.74 M(-60.4%) |
| June 2019 | - | $29.61 M(-23.1%) |
| Mar 2019 | - | $38.51 M(+23.4%) |
| Dec 2018 | $31.21 M(+50.6%) | $31.21 M(+28.1%) |
| Sept 2018 | - | $24.36 M(+17.5%) |
| Dec 2017 | $20.73 M(-26.4%) | $20.73 M(+1917.0%) |
| Sept 2017 | - | $1.03 M(+9.5%) |
| June 2017 | - | $938.40 K(+51.6%) |
| Mar 2017 | - | $618.80 K(-6.7%) |
| Dec 2016 | $28.16 M(+3590.3%) | - |
| Dec 2016 | - | $663.30 K(-55.8%) |
| Sept 2016 | - | $1.50 M(+12.6%) |
| June 2016 | - | $1.33 M(+29.2%) |
| Mar 2016 | - | $1.03 M(+35.1%) |
| Dec 2015 | $763.00 K(+11.1%) | $763.00 K(+0.5%) |
| Sept 2015 | - | $759.00 K(+51.2%) |
| June 2015 | - | $502.00 K(-13.6%) |
| Mar 2015 | - | $581.00 K(-15.4%) |
| Dec 2014 | $687.00 K(-57.4%) | $687.00 K(-44.5%) |
| Sept 2014 | - | $1.24 M(+17.6%) |
| June 2014 | - | $1.05 M(-33.8%) |
| Mar 2014 | - | $1.59 M(-1.5%) |
| Dec 2013 | $1.61 M(+0.5%) | $1.61 M(+7.3%) |
| Sept 2013 | - | $1.50 M(-4.8%) |
| June 2013 | - | $1.58 M(-5.6%) |
| Mar 2013 | - | $1.67 M(+4.2%) |
| Dec 2012 | $1.61 M(-36.7%) | $1.61 M(-8.8%) |
| Sept 2012 | - | $1.76 M(-50.3%) |
| June 2012 | - | $3.54 M(+8.8%) |
| Mar 2012 | - | $3.26 M(+28.4%) |
| Dec 2011 | $2.54 M(-35.3%) | $2.54 M(+15.4%) |
| Sept 2011 | - | $2.20 M(-15.9%) |
| June 2011 | - | $2.61 M(-21.2%) |
| Mar 2011 | - | $3.31 M(-15.5%) |
| Dec 2010 | $3.92 M(+85.5%) | $3.92 M(+85.5%) |
| Sept 2010 | - | $2.11 M(-21.1%) |
| June 2010 | - | $2.68 M(+25.2%) |
| Mar 2010 | - | $2.14 M(+1.2%) |
| Dec 2009 | $2.11 M(+3.7%) | $2.11 M(+85.3%) |
| Sept 2009 | - | $1.14 M(-7.9%) |
| June 2009 | - | $1.24 M(+7.8%) |
| Mar 2009 | - | $1.15 M(-43.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $2.04 M(-51.6%) | $2.04 M(+55.5%) |
| Sept 2008 | - | $1.31 M(-43.5%) |
| June 2008 | - | $2.32 M(-17.0%) |
| Mar 2008 | - | $2.79 M(-33.7%) |
| Dec 2007 | $4.22 M(-5.0%) | $4.22 M(+24.8%) |
| Sept 2007 | - | $3.38 M(+32.9%) |
| June 2007 | - | $2.54 M(-34.9%) |
| Mar 2007 | - | $3.91 M(-11.9%) |
| Dec 2006 | $4.44 M(+50.7%) | $4.44 M(+29.2%) |
| Sept 2006 | - | $3.43 M(-1.6%) |
| June 2006 | - | $3.49 M(+66.3%) |
| Mar 2006 | - | $2.10 M(-28.8%) |
| Dec 2005 | $2.94 M(+78.2%) | $2.94 M(+2.0%) |
| Sept 2005 | - | $2.88 M(-11.2%) |
| June 2005 | - | $3.25 M(+18.8%) |
| Mar 2005 | - | $2.73 M(+65.6%) |
| Dec 2004 | $1.65 M(-30.9%) | $1.65 M(-9.1%) |
| Sept 2004 | - | $1.82 M(-2.7%) |
| June 2004 | - | $1.87 M(+1.0%) |
| Mar 2004 | - | $1.85 M(-22.6%) |
| Dec 2003 | $2.39 M(+88.3%) | $2.39 M(+34.7%) |
| Sept 2003 | - | $1.77 M(-7.7%) |
| June 2003 | - | $1.92 M(+101.3%) |
| Mar 2003 | - | $955.00 K(-24.7%) |
| Dec 2002 | $1.27 M(+127.0%) | $1.27 M(-23.8%) |
| Sept 2002 | - | $1.67 M(+31.6%) |
| June 2002 | - | $1.26 M(+37.8%) |
| Mar 2002 | - | $918.00 K(+64.2%) |
| Dec 2001 | $559.00 K(-13.7%) | $559.00 K(-19.5%) |
| Sept 2001 | - | $694.00 K(-4.9%) |
| June 2001 | - | $730.00 K(+35.7%) |
| Mar 2001 | - | $538.00 K(-17.0%) |
| Dec 2000 | $648.00 K(-69.1%) | $648.00 K(-37.6%) |
| Sept 2000 | - | $1.04 M(-1.9%) |
| June 2000 | - | $1.06 M(+39.4%) |
| Mar 2000 | - | $759.00 K(-63.9%) |
| Dec 1999 | $2.10 M(+250.0%) | $2.10 M(+31.3%) |
| Sept 1999 | - | $1.60 M(+100.0%) |
| June 1999 | - | $800.00 K(-38.5%) |
| Mar 1999 | - | $1.30 M(+116.7%) |
| Dec 1998 | $600.00 K(-60.0%) | $600.00 K(-50.0%) |
| Sept 1998 | - | $1.20 M(-7.7%) |
| June 1998 | - | $1.30 M(+62.5%) |
| Mar 1998 | - | $800.00 K(-46.7%) |
| Dec 1997 | $1.50 M(+150.0%) | $1.50 M(+66.7%) |
| Sept 1997 | - | $900.00 K(+12.5%) |
| June 1997 | - | $800.00 K(+14.3%) |
| Mar 1997 | - | $700.00 K(+133.3%) |
| Dec 1996 | $600.00 K(+20.0%) | - |
| Sept 1996 | - | $300.00 K(-40.0%) |
| June 1996 | $500.00 K(0.0%) | $500.00 K(0.0%) |
| Mar 1996 | - | $500.00 K(0.0%) |
| Dec 1995 | - | $500.00 K(-28.6%) |
| Sept 1995 | - | $700.00 K(+40.0%) |
| June 1995 | $500.00 K(0.0%) | $500.00 K(+25.0%) |
| Mar 1995 | - | $400.00 K(-20.0%) |
| Dec 1994 | - | $500.00 K(0.0%) |
| Sept 1994 | - | $500.00 K(0.0%) |
| June 1994 | $500.00 K | $500.00 K(0.0%) |
| Mar 1994 | - | $500.00 K(-16.7%) |
| Dec 1993 | - | $600.00 K(+20.0%) |
| Sept 1993 | - | $500.00 K |
FAQ
- What is Moderna annual accounts payable?
- What is the all time high annual accounts payable for Moderna?
- What is Moderna quarterly accounts payable?
- What is the all time high quarterly accounts payable for Moderna?
- What is Moderna quarterly accounts payable year-on-year change?
What is Moderna annual accounts payable?
The current annual accounts payable of MRNA is $520.00 M
What is the all time high annual accounts payable for Moderna?
Moderna all-time high annual accounts payable is $520.00 M
What is Moderna quarterly accounts payable?
The current quarterly accounts payable of MRNA is $373.00 M
What is the all time high quarterly accounts payable for Moderna?
Moderna all-time high quarterly accounts payable is $520.00 M
What is Moderna quarterly accounts payable year-on-year change?
Over the past year, MRNA quarterly accounts payable has changed by -$147.00 M (-28.27%)